Biosimilars

COVID-19

Cataract Surgery

Cataract

Cataract Therapeutics

NeuroOp Guru

The Residency Report

Clinical Diagnosis

Cornea

Dry Eye Awareness

Dry Eye

Gene Therapy

Geographic Atrophy

IOL Advances

Imaging

Glaucoma Awareness

Glaucoma Insights

Therapeutic Glaucoma

Interventional Glaucoma

Ocular Allergy

Ocular Surface Disease

Optic Relief

Optometry

Pediatrics

Pharmacy

Indispensable

Practice Management

Presbyopia

Ptosis

Refractive Surgery

Refractive

Retina

Surgery

Technology

Therapeutics

Understanding Antibiotic Resistance

Workplace

News

All News

Contributors

Money Matters

Media

All Videos

Expert Interviews

Medical World News

Podcasts

Case Based Roundtable Series

Case of the Quarter

EyeView

Grand Rounds

Insights

Rapid Readout

Viewpoints

What’s Your WhEYE?

Conferences

Conference Coverage

Conference Listing

Events

Publications

Digital Edition

Europe Ophthalmology Times

Modern Retina

Supplements and Featured Publications

Partners

Subscribe

Resources

Job Board

Articles

Eyetronic is a noninvasive treatment for glaucoma that provides external neural stimulation to the optic nerve of patients.

First US patient receives Eyetronic glaucoma treatment at Glaucoma Center of San Francisco

OpenAI's ChatGPT-4o enhances ophthalmological image generation, producing realistic retinal photographs while highlighting the need for further research in training datasets.

Researchers explore ChatGPT4o's ability to generate realistic retinal fundus images

Role of mucormycosis infection on vision in diabetic patient

Sheryl brings a wealth of editorial experience to MJH Life Sciences’ Eye Care Network, having engaged with the readers and the greater ophthalmic community of 

for more than 20 years. As Group Editorial Director, Sheryl’s purview extends across the print and digital network of 

Ophthalmology Times, Ophthalmology Times Europe, Modern Retina 

 Prior to ophthalmology, Sheryl previously covered the fields of audiology and confectionery science/technology/manufacturing.

Sheryl is also passionate about the mission, vision and values of Ophthalmic World Leaders (OWL) and recently completed her term on its Board of Directors. She continues to volunteer as Editor-in-Chief of the organization’s 

Magazine. In 2013, she was honored with the group’s inaugural Rising Star Award.

In addition, she has served as a judge for 

 Health Care Heroes Awards program as well as the Jesse H. Neal National Business Journalism Awards.

Videos

President Joel S. Schuman, MD, highlights the group’s mission and vision for the future—uniting 17 working groups and over 80 stakeholders.



CCOI sets the stage for global ophthalmic innovation at Stanford Summit on July 23

Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance clinical and patient care.

About

Advertise

Privacy

Editorial Info

Editorial Board

Terms and Conditions

Contact Us

Do Not Sell My Personal Information

Ophthalmology Times – Clinical Insights for Eye Specialists

Facebook

Instagram

LinkedIn

Spotlight

Clinical

Glaucoma

Your unrestricted view into eyecare conferences across the spectrum. Gain exclusive access to Ophthalmology Times® expert-led conference coverage from major meetings throughout the year featuring articles, videos, and insights shared by prominent experts of the ophthalmic community.

1rem

Five years after the COVID-19 pandemic shutdown reshaped how the world gathers, here's how some of ophthalmology’s leading associations are still applying lessons forged in crisis

When the world went virtual: How ophthalmology’s conferences stayed on track

A combination of canaloplasty and goniotomy provides sustained IOP reduction and decreases medication burden with a strong safety profile, making it a valuable option for glaucoma management.

AGS 2025: A look at Gemini and the MIGS revolution with Mona Kaleem, MD

The Keralink Trial was the first randomized clinical trial that tested the hypothesis that corneal cross-linking (CXL) might decrease keratoconus progression in children compared with the use of spectacles or contact lenses. 

APAO 2023: Keralink trial: Efficacy and safety of corneal cross-linking for children with Keratoconus

APAO

Assistive devices empower patients with central vision loss to regain independence, enhancing daily activities and reducing reliance on low vision centers.

Q&A: Meeting the need for low vision services with wearable tech

ARVO

Ophthalmologists discuss the most impactful advancements reshaping patient care over five decades.

50 years of ophthalmology: What changed the game (Part 2)

ASCRS

Presentation highlights include 48-month data from the OAKS and DERBY trials as well as the GALE open-label extension.

Apellis announces 5 abstracts to be orally presented at the American Society of Retina Specialists (ASRS) annual meeting

ASRS

Charles Wykoff, MD, took the stage at the American Society of Retina Specialists annual meeting in New York to present a talk titled “Suprachoroidal Delivery of RGX-314 Gene Therapy for Diabetic Retinopathy: Phase II ALTITUDE Study.” He discusses results of the trial, which showed improvements for patients diagnosed with diabetic macular edema and non-proliferative diabetic retinopathy, with notable improvements according to the Diabetic Retinopathy Severity Scale.

Wykoff: RGX-314 highlights DRSS improvements in patients diagnosed with DME, NPDR

ASRS Preview

Examining the performance of AI algorithms versus human graders in neovascular age-related macular degeneration

Angiogenesis 2025: AI-driven home OCT insights with Anat Loewenstein, MD

Angiogenesis

CCS 2025: Managing laser corneal refractive surgery and implantable collamer lens based procedures

Collaborative Care Symposium

CIME 2025: Neda Shamie, MD, on expanding options in pharmacological presbyopia management

Controversies in Modern Eye Care

The 22nd  European Society of Retina Specialists Congress kicks off Thursday at the Congress Centre Hamburg in Hamburg, Germany.

EURETINA 2022: Stepping into a new era in ophthalmology

EURETINA

At the EnVision Summit 2025, medical students were given awards for best poster presentation. In exclusive interviews, they spoke with Ophthalmology Times about their award-winning posters and research. 

Winners of best poster presentation award at EnVision Summit 2025

EnVision Summit

Lloyd Clark, MD, discusses the evolution and current practices in the treatment of common retinal diseases such as age-related macular degeneration, diabetic macular edema, and retinal vein occlusion.

EyeCon 2024: Current trends in the treatment of common retinal diseases

EyeCon

Ying Han, MD, PhD discusses glaucoma management strategies, including transitioning care between ophthalmologists and optometrists, improving diagnosis, and the hope for future glaucoma developments.

Managing the complexities of glaucoma care with Ying Han, MD, PhD

GLAUCOMA 360

Cutting-edge advances are outlined at Hawaiian Eye and Retina 2024

Ophthalmology in paradise

Hawaiian Eye and Retina

IKA Keratoconus Symposium and Controversies in Modern Eye Care shone brightly in May

IKA Keratoconus Symposium, CIME spark educational opportunities

IKA Keratoconus Symposium

At the 2025 International SPECTRALIS Symposium—And Beyond (ISS), Chauhan discussed how two-photon microscopy enables precise, non-invasive monitoring of retinal ganglion cell function in living subjects.

Balwantray C. Chauhan, PhD, explores in vivo functional imaging of single retinal ganglion cells with two-photon imaging

International SPECTRALIS Symposium – and Beyond

Sumit Sharma, MD, sat down with Sydney Crago of Modern Retina to discuss his presentation on the 3 tyrosine kinase inhibitors currently in development for the treatment of retina conditions at the Retina Society meeting being held this year in Lisbon, Portugal. 

Retina Society 2024: A comparison of tyrosine kinase inhibitors in development

The Retina Society

Laura Kopplin, MD, PhD, spoke with our team to share insights from her presentation at the Women in Ophthalmology Summer Symposium 2023 in Marco Island, Florida.

WIO 2023: Multimodal imaging in uveitis